SCND
SCIENTIFIC INDUSTRIES INC
0.00 (0.00%)0.83USD0成交股數9.9M市值–本益比(近四季)1.7股價營收比+36.0%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.5M+36% | 1.2M+30% | 1.6M+22% | 1.4M-47% | 1.1M-56% | 942K-66% | 1.3M-48% | 2.6M-11% | 2.5M | 2.7M | 2.6M | 3.0M |
| 營業成本 | 848K | 757K | 1.7M | 765K | 704K | 598K | 655K | 1.4M | 1.4M | 1.5M | 1.4M | 1.6M |
| 毛利 | 623K+65% | 470K+36% | −57K-108% | 639K-51% | 377K-64% | 344K-72% | 680K-42% | 1.3M-4% | 1.0M | 1.2M | 1.2M | 1.4M |
| 毛利率 | 42.3% | 38.3% | -3.5% | 45.5% | 34.8% | 36.5% | 51.0% | 48.8% | 41.9% | 45.0% | 45.7% | 45.3% |
| 研發費用 | 695K | 704K | 537K | 621K | 677K | 652K | 644K | 666K | 711K | 1.2M | 896K | 685K |
| 銷售管理費用 | 554K | 747K | 692K | 804K | 745K | 1.0M | 781K | 1.1M | 1.5M | 1.7M | 896K | 1.3M |
| 營業利益 | −1.3M-30% | −1.7M-20% | −2.5M+57% | −1.5M+14% | −1.8M-13% | −2.1M-11% | −1.6M-30% | −1.3M-40% | −2.1M | −2.3M | −2.2M | −2.2M |
| 營業利益率 | -86.6% | -135.9% | -151.2% | -108.4% | -168.3% | -221.7% | -117.3% | -50.5% | -84.1% | -85.5% | -86.1% | -74.6% |
| 稅後淨利 | −1.2M-19% | −1.6M-11% | −1.9M+62% | 4.0M-411% | −1.5M-26% | −1.8M-20% | −1.2M-46% | −1.3M-44% | −2.1M | −2.2M | −2.2M | −2.3M |
| 淨利率 | -83.9% | -129.5% | -117.6% | 284.5% | -141.0% | -188.7% | -88.4% | -48.5% | -82.6% | -81.2% | -85.1% | -76.8% |
| 稀釋 EPS | -0.10-23% | -0.13-19% | -0.16+45% | 0.34-383% | -0.13-165% | -0.16 | -0.11-65% | -0.12 | 0.20 | – | -0.31 | – |
| 稀釋股數 | 11.9M | 11.9M | 11.3M | 11.7M | 11.3M | 10.5M | 10.5M | 10.5M | 10.4M | 10.1M | 7.0M | 7.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 617K | 798K | 955K | 1.2M | 891K | 470K | 564K | 561K | 352K | 796K | 515K | 645K |
| 應收帳款 | 517K | 535K | 866K | 678K | 966K | 1.2M | 1.4M | 1.2M | 1.1M | 1.2M | 1.3M | 1.1M |
| 存貨 | 1.9M | 1.6M | 1.7M | 2.0M | 4.4M | 4.4M | 5.4M | 5.4M | 4.9M | 4.9M | 5.3M | 5.3M |
| 總資產 | 10.1M | 11.1M | 12.6M | 14.6M | 10.2M | 10.6M | 13.3M | 14.3M | 15.5M | 16.7M | 13.0M | 14.2M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 2.0M | 2.0M | 1.9M | 2.1M | 2.2M | 2.8M | 2.4M | 2.6M | 2.9M | 2.8M | 3.2M | 2.9M |
| 股東權益 | 8.1M | 9.1M | 10.7M | 12.5M | 7.9M | 7.8M | 10.9M | 11.7M | 12.6M | 13.9M | 9.9M | 11.3M |
| 負債比 | 20.1% | 17.9% | 15.4% | 14.4% | 21.8% | 26.5% | 17.8% | 18.2% | 18.8% | 17.0% | 24.3% | 20.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −994K-35% | – | – | – | −1.5M | – | – | −1.6M | – | – | – |
| 資本支出 | – | 6K | – | – | – | 26K | – | – | 48K | – | – | – |
| 自由現金流 | – | −1,000K-35% | – | – | – | −1.5M | – | – | −1.6M | – | – | – |
| 折舊攤銷 | – | 55K | – | – | – | 167K | – | – | 188K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -81.5% | – | – | – | -164.3% | – | – | -64.9% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 5.1M
| Benchtop Laboratory Equipment | 3.8M | 74.3% | +20.8% |
|---|---|---|---|
| Bioprocessing Systems | 1.3M | 25.7% | -23.1% |
| Consolidated Entity 小計 | 5.1M | 100.0% | +5.4% |
產品／服務2025 年度 · 115K
| Subscriptions | 115K | 100.0% | +71.8% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 5.1M | +5.4% | −1.2M | -24.1% | -0.11 | −8.2M |
| FY2024 | 4.8M | -56.8% | −6.4M | -134.4% | -0.61 | −3.8M |
| FY2023 | 11.1M | -2.5% | −9.1M | -81.8% | -1.27 | −6.3M |
| FY2022 | 11.4M | +16.6% | −13.7M | -119.9% | – | −5.9M |
| FY2021 | 9.8M | +25.6% | −3.7M | -37.6% | -1.00 | −3.8M |
| FY2020 | 7.8M | -23.7% | −703K | -9.0% | -0.46 | −219K |
| FY2019 | 10.2M | – | 646K | 6.3% | 0.43 | 972K |